Sigmaroc PLC
LSE:SRC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
70.4
129.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Sigmaroc PLC
SigmaRoc Plc engages in investing and acquiring projects in the construction materials sector. The firm seeks to create value by purchasing assets in fragmented construction materials markets through active management and by forming the assets into larger groups. The firm also seeks to derisk its investments through asset backing at its projects. The Company’s SigmaPPG (PPG) Platform is covering the United Kingdom market including Allen (Concrete) Limited, Poundfield Products Ltd and Cheshire Concrete Products (CCP). SigmaRoc’s Benelux Platform is a construction aggregates platform covering the Benelux market including Granulats du Hainaut, Stone, B-Mix and Casters.
SigmaRoc Plc engages in investing and acquiring projects in the construction materials sector. The firm seeks to create value by purchasing assets in fragmented construction materials markets through active management and by forming the assets into larger groups. The firm also seeks to derisk its investments through asset backing at its projects. The Company’s SigmaPPG (PPG) Platform is covering the United Kingdom market including Allen (Concrete) Limited, Poundfield Products Ltd and Cheshire Concrete Products (CCP). SigmaRoc’s Benelux Platform is a construction aggregates platform covering the Benelux market including Granulats du Hainaut, Stone, B-Mix and Casters.
Strong Performance: SigmaRoc delivered record results despite a tough market, with margins, EPS, and leverage all improving.
Revenue & EBITDA: Revenue topped GBP 500 million, up 13% year-on-year, and EBITDA reached GBP 118 million, up 21% year-on-year.
Synergy Delivery: Management offset weak volumes and pricing pressure by aggressively realizing cost and revenue synergies.
EPS Growth: Earnings per share hit a new high of 4.7p for the half, up over 50% year-on-year.
Leverage Down: Net debt fell to GBP 498 million, with leverage dropping from 2.6x to 2.0x year-on-year.
Guidance Maintained: Full-year expectations remain unchanged; management is optimistic about 2026 as European infrastructure programs ramp up.
Positioned for Recovery: The group is preparing for demand growth from European stimulus and reconstruction efforts, especially in Germany and potentially Ukraine.
